Zacks Investment Research
20 Aug 2026, 13:51 UTC · 7w ago
Impact · against what's priced in
The article suggests these four healthcare stocks as defensive hedges against imminent Fed rate hikes. While theoretically positive for defensive positioning, the impact is marginal as the market is already aware of the Fed's hawkish posture and inflation trends.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Federal Reserve officials believe a rate hike is almost inevitable if inflation remains high.
So whatHigher interest rates increase borrowing costs for consumers and companies, typically weighing on risk asset valuations.
More negative than 99% of claims this week
Three FOMC committee members voted in favor of a 25-basis-point rate hike at the last meeting.
Continue reading
5 related stories
Bioventus is positioned as a safe-bet defensive stock to safeguard portfolios against potential interest rate volatility.
Read from the article alone
No priced-in read yet
Centene is highlighted as a defensive healthcare play that can mitigate risks associated with inevitable rate hikes.
Read from the article alone
No priced-in read yet
Amneal Pharmaceuticals is recommended as a defensive asset to navigate a turbulent market and rising borrowing costs.
Read from the article alone
Scored by the NIS engine · methodology.
More negative than 91% of claims this week
Geopolitical tensions between the United States and Iran have escalated with no immediate plans for peace talks.
More negative than 86% of claims this week
The Federal Reserve kept interest rates unchanged in July at a range of 3.5-3.75%.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
Explicitly recommended as a 'safe bet' defensive stock amid potential rate hikes.
More positive than 89% of ticker scores this week
Explicitly recommended as a 'safe bet' defensive stock amid potential rate hikes.
More positive than 89% of ticker scores this week
Explicitly recommended as a 'safe bet' defensive stock amid potential rate hikes.
More positive than 89% of ticker scores this week
Explicitly recommended as a 'safe bet' defensive stock amid potential rate hikes.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
10h ago
−11.0%
Price is moving against the score
$13.06 vs $14.68 close before publication (Aug 19) · not market-adjusted
BVS chart →+9.9%
Price agrees with the score
$19.91 vs $18.11 close before publication (Aug 19) · not market-adjusted
AMRX chart →+1.0%
Price agrees with the score
$65.36 vs $64.70 close before publication (Aug 19) · not market-adjusted
CNC chart →
